Back to Search Start Over

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.

Authors :
King, Lisa A.
Lameris, Roeland
de Gruijl, Tanja D.
van der Vliet, Hans J.
Source :
Frontiers in Immunology; 11/20/2018, pN.PAG-N.PAG, 1p
Publication Year :
2018

Details

Language :
English
ISSN :
16643224
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
133121096
Full Text :
https://doi.org/10.3389/fimmu.2018.02606